Thu, May 30, 2019
Tue, May 28, 2019
Wed, May 29, 2019

Kevin Caliendo Downgraded (TEVA) to Hold and Decreased Target to $12 on, May 28th, 2019

Kevin Caliendo of UBS, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Decreased Target from $22 to $12 on, May 28th, 2019.

Kevin has made no other calls on TEVA in the last 4 months.



There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 3 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jacob Hughes of "Wells Fargo" Maintained at Hold with Decreased Target to $17 on, Thursday, May 9th, 2019
  • David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $17 on, Wednesday, March 6th, 2019
  • Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $20 on, Thursday, February 14th, 2019


These are the ratings of the 2 analyists that currently disagree with Kevin


  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Decreased Target to $23 on, Thursday, April 11th, 2019
  • Elliot Wilbur of "Raymond James" Upgraded from Hold to Buy on, Thursday, February 14th, 2019